 RALEIGH, NC ACCESSWIRE March 9, 2022 9 Meters Biopharma, Inc. NASDAQ:NMTR, a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, announced today that John Temperato, President Chief Executive Officer of 9 Meters, will present at the Oppenheimer 32nd Annual Healthcare Conference on Wednesday, March 16, 2022, at 10:00 a.m. ET. The conference will take place on March 15-17, 2022, and is being held virtually. 